Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mol Biol Rep. 2020 May;47(5):3469-3474. doi: 10.1007/s11033-020-05432-4. Epub 2020 Apr 10.
Colorectal cancer (CRC) is known as the most common form of malignancies in the world and its occurrence is annually increasing. Due to the relatively high death rates in patients, finding better diagnostic and prognostic factors are required. Substance P (SP) belongs to the tachykinin family that acts as an immunomodulator by binding to the neurokinin-1 receptor (NK1R). The interaction of SP with NK1R might be involved in tumor cell proliferation, angiogenesis, and migration. Hence, this study was aimed to evaluate the serum SP level and tissue distribution of NK1Rs in CRC. Also, we assessed the relationship between tissue distribution of NK1R and some different tumor characteristics, including tumor size, and lymph node status. Recruiting 38 patients primarily diagnosed with CRC, the tissue distribution of NK1R was immunohistochemically evaluated in tumor tissues and their adjacent normal tissue. The serum level of SP was measured using an ELISA method in both cases and healthy control group. The SP value was significantly increased in the serum of patients in comparison with the healthy group (p = 0.001). Tumor tissues expressed a higher number of NK1R than adjacent normal tissues (p = 0.01) considering both the percentage of stained cells and intensity of staining. However, there was not any statistically significant relevance between NK1R distribution and tumor characteristics. The SP/NK1R system is involved in tumorigenesis of CRC, and might be suggested as a potent prognostic or diagnostic factor, or a new target in the treatment of CRC.
结直肠癌(CRC)是世界上最常见的恶性肿瘤之一,其发病率逐年上升。由于患者的死亡率相对较高,因此需要寻找更好的诊断和预后因素。P 物质(SP)属于速激肽家族,通过与神经激肽-1 受体(NK1R)结合发挥免疫调节剂作用。SP 与 NK1R 的相互作用可能参与肿瘤细胞增殖、血管生成和迁移。因此,本研究旨在评估 CRC 患者血清 SP 水平和 NK1R 的组织分布,并评估 NK1R 组织分布与肿瘤大小和淋巴结状态等一些不同肿瘤特征之间的关系。招募了 38 名初诊为 CRC 的患者,采用免疫组织化学方法评估肿瘤组织及其相邻正常组织中 NK1R 的组织分布。采用 ELISA 法测量两组患者血清 SP 水平和健康对照组。与健康组相比,患者血清 SP 值显著升高(p=0.001)。考虑到染色细胞的百分比和染色强度,肿瘤组织表达的 NK1R 数量均高于相邻正常组织(p=0.01)。然而,NK1R 分布与肿瘤特征之间没有统计学上的显著相关性。SP/NK1R 系统参与 CRC 的肿瘤发生,可能被建议作为一个有力的预后或诊断因素,或作为 CRC 治疗的新靶点。